Brian Slomovitz, Director of Gynecologic Oncology at Mount Sinai Medical Center, shared on LinkedIn:
“It’s going to be an exciting week for our patients suffering from endometrial cancer. Several studies will be presented and published that demonstrate how clinical research can make a difference and improve treatment options.
This study was published this month in International Journal of Gynecological Cancer (IJGC) demonstrates that a novel hormonal-based therapy is effective in treating patients with endometrial cancer who desire or require an alternative to surgery.
I was honored to have the opportunity to be the study chair of this trial working closely with Lucy Gilbert, Yvonne Lin Genentech Noelle Cloven
Imagine if young women with endometrial cancer can have a fertility preserving option!!! This study reports on one possible way for this to happen. The future is bright!”
Title: Pathologic response and molecular correlates of giredestrant in patients with grade 1 clinical stage IA endometrioid endometrial cancer: the phase II endomERA study
Authors: Lucy Gilbert, Nimesh Nagarsheth, Susie Lau, Alberto Farolfi, Noelle Cloven, Marcin Misiek, Corby Arthur, Jingyuan Chen, Miranda Craft, Roshni Patel-Romero, Jackson Liang, Victor K. Khor, Yvonne G. Lin, Brian Slomovitz
Other articles featuring Brian Slomovitz on OncoDaily.